5-Chloro-2-methyl-1,8-naphthyridine → (5-Methoxy-2-phenylsulfanyl-phenyl)-(7-methyl-[1,8]naphthyridin-4-yl)-amine
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([S:10][C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)=[C:7]([NH2:9])[CH:8]=1.Cl[C:18]1[CH:27]=[CH:26][N:25]=[C:24]2[C:19]=1[CH:20]=[CH:21][C:22]([CH3:28])=[N:23]2>>[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([S:10][C:11]2[CH:12]=[CH:13][CH:14]=[CH:15][CH:16]=2)=[C:7]([NH:9][C:18]2[C:19]3[C:24](=[N:23][C:22]([CH3:28])=[CH:21][CH:20]=3)[N:25]=[CH:26][CH:27]=2)[CH:8]=1Participants
3
Procedure
The product from Example 9b (69 mg, 0.30 mmol) was reacted with the product from Example 1d (53 mg, 0.30 mmol) following the procedure from Example 1g giving the title compound as a hydrochloride salt after trituration with solid (119 mg, 96%). 1H NMR (300 MHz, DMSO-d6) δ ppm: 2.75 (s, 3H) 3.83 (s, 3H) 6.34 (d, J=6.99 Hz, 1H) 7.07 (m, 7H) 7.57 (d, J=8.46 Hz, 1H) 7.76 (d, J=8.46 Hz, 1H) 8.85 (d, J=6.99 Hz, 1H) 8.99 (d, J=8.46 Hz, 1H) 11.16 (br s, 1H) 14.43 (brs, 1H); MS (ESI+) m/z 374 (M−Cl)+; (ESI−) m/z 372 (M−HCl)−.
Sources & evidence
- ORD record
- ord-cd6aa2bd6c8e4a07b33506ed381da4ea
- Source dataset
- uspto-grants-2010_07
- Patent number
- US07763731B2
Reaction notes
Loading…